EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewLeitlinieOpen Access · CC BY 4.0

Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice

Kate Maslin iD, Jill Shawe iD, Sinead Blowers iD, Michael Ceulemans iD, Kathryn Hart iD, Sam Schoenmakers iD, Amihai Rottenstreich iD, Heather Hopper iD, Mojca Jensterle iD, Angela C Flynn, Sarah Siegelaar iD, Annick Bogaerts iD und 8 weitere

Obesity Reviews · 29.07.2026

DOI: 10.1111/obr.70203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 29.07.2026. Verfasst von Kate Maslin und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Midwifery, University of Plymouth, Plymouth, Devon, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pregnancy concurrent with incretin‐based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin‐based medications in relation to preconception, pregnancy, and postnatal health, and to propose expert guidelines for clinical practice.

Methods

An international expert multidisciplinary group was formed. Research questions relevant to women's reproductive health and incretin‐based medications were refined collaboratively, utilizing a lifecourse approach. A systematic search was undertaken on July 23, 2025, across several databases and grey literature sources. Primary data from human studies were prioritized above animal studies. Titles, abstracts, and full text articles were screened independently by two authors. Data were extracted by two people independently using a pre‐defined proforma and synthesized narratively. Consensus recommendations were made.

Results

Thirty‐four articles were included in the evidence synthesis: 11 randomized trials, nine observational studies, two pharmacovigilance reviews, nine case reports/series, two animal studies, and one ex vivo study. No qualitative studies were identified. Evidence was found for 18/32 (56.3%) research questions. Most studies related to preconception or pregnancy usage; two addressed contraception, and one was about lactation. The sample size of exposed pregnancies ranged from 1 to 4267. Three studies reported exposure throughout pregnancy. Three studies investigated postpartum usage. One (animal) study had offspring data beyond birth. No studies reported an increase in congenital anomalies.

Conclusion

Clinical practice and research recommendations were made based on current available evidence and evidence gaps, encompassing contraception, preconception, nutritional, pregnancy monitoring, lactation, and longer‐term outcomes.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1fetalincretinmaternalobesitypostpartumpreconceptionpregnancy

Autor:innen und Institutionen

  • School of Nursing and Midwifery, University of Plymouth, Plymouth, Devon, UK.
  • REALIFE Research Group, Research Unit Woman and Child, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Royal Cornwall NHS Trust, Truro, Cornwall, UK.
  • Research Group Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Research Foundation Flanders (FWO), Brussels, Belgium.
  • Discipline of Nutrition, Exercise, Chronobiology and Sleep, Faculty of Health & Medical Sciences, University of Surrey, Guildford, Surrey, UK.

ORCID-Profile: Kate Maslin, Jill Shawe, Sinead Blowers, Michael Ceulemans, Kathryn Hart, Sam Schoenmakers, Amihai Rottenstreich, Heather Hopper, Mojca Jensterle, Sarah Siegelaar, Annick Bogaerts, Isy Douek, Nicola Heslehurst, Dries Ceulemans, Tricia Tan, Johnathan Pinkney, Martin Whyte, Shahrad Taheri, Roland Devlieger

Zitieren

APA

Maslin, K., Shawe, J., Blowers, S., Ceulemans, M., Hart, K., Schoenmakers, S., Rottenstreich, A., Hopper, H., Jensterle, M., Flynn, A. C., Siegelaar, S., Bogaerts, A., Douek, I., Heslehurst, N., Ceulemans, D., Tan, T., Pinkney, J., Whyte, M., Taheri, S., & Devlieger, R. (2026). Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice. Obesity Reviews. https://doi.org/10.1111/obr.70203

Vancouver

Maslin K, Shawe J, Blowers S, Ceulemans M, Hart K, Schoenmakers S, et al. Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice. Obesity Reviews. 2026. doi:10.1111/obr.70203

BibTeX
@article{Maslin2026,
  author = {Maslin, Kate and Shawe, Jill and Blowers, Sinead and Ceulemans, Michael and Hart, Kathryn and Schoenmakers, Sam and Rottenstreich, Amihai and Hopper, Heather and Jensterle, Mojca and Flynn, Angela C and Siegelaar, Sarah and Bogaerts, Annick and Douek, Isy and Heslehurst, Nicola and Ceulemans, Dries and Tan, Tricia and Pinkney, Johnathan and Whyte, Martin and Taheri, Shahrad and Devlieger, Roland},
  title = {Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice},
  journal = {Obesity Reviews},
  year = {2026},
  doi = {10.1111/obr.70203}
}
Kostenlos starten →